Home > > > Report Detail

Investigation Report on China's Recombinant Human Interferon α2b Market, 2018-2022

Publisher Name :
Date: 15-Jan-2019
No. of pages: 30

Description

An interferon is a group of host-specific glycoproteins secreted by cells in response to virus infections or other factors. As a cytokine, it can defend against a wide variety of viruses by stimulating the synthesis of new effector proteins in interaction with the receptors on uninfected cells though it cannot directly kill or inhibit the viruses in cells. Besides, it can achieve immunoregulation and anti-cancer effects by enhancing the viability of lymphocytes, macrophages and natural killer cells.

In 1986, Intron A, the world's first Recombinant Human Interferon α2b, was launched by Schering Plough that was later acquired by MSD, and approved by the FDA to be used for the treatment of chronic hepatitis B. In 1997, Tianjin Sinobioway Biomedicine Co., Ltd.'s Recombinant Human Interferon α2b was approved to be sold in China, followed by the counterparts of Anhui Anke Biotechnology (Group) Co., Ltd., Zhejiang Beisheng Medicine Industry Hansheng Pharmaceutical Co., Ltd. and Schering-Plough that were approved in 1998, 1999 and 2007 respectively.

Recombinant Human Interferon α2b has been approved by the China Food and Drug Administration to be sold in the dosage forms of freeze-dried powder injection, injection, suppository, cream (ointment), eye drops, etc. The main indications include acute and chronic viral hepatitis infections (hepatitis B and hepatitis C), condyloma acuminatum, hairy cell leukemia, etc. and vary among dosage forms.

CRI estimates that by the end of 2018, more than 90 million people in China are infected with hepatitis B virus and 8 million carry hepatitis C virus. With the increasing incidence of herpes, 80%-90% of the Chinese population are infected with herpes zoster virus, and 30% of the infected may develop chickenpox, and the rest 70% will be attacked by herpes zoster when they are weak. Furthermore, over 40% of married women in China are suffering from cervical erosion.

Market research, the sales value of Recombinant Human Interferon α2b showed an upward trend after the drug was launched in China, reaching about CNY 271 million in 2017. The injections, capsules and gels take up a large market share, with Shanghai Huaxin High Biotechnology Inc., Zhaoke Pharmaceutical (Hefei) Co. Ltd. and Schering-Plough as the top market players by sales value.

Topics Covered:


  • Status of China's Recombinant Human Interferon α2b market

  • Major manufacturers of Recombinant Human Interferon α2b in China

  • Prices of Recombinant Human Interferon α2b in China

  • Major factors influencing development of Recombinant Human Interferon α2b in China

  • Prospect of China's Recombinant Human Interferon α2b market from 2018 to 2022

Investigation Report on China's Recombinant Human Interferon α2b Market, 2018-2022

Table of Contents

1 Relevant Concepts of Recombinant Human Interferon α2b
1.1 Indications for Recombinant Human Interferon α2b
1.2 Development of Recombinant Human Interferon α2b in China
1.3 Governmental Approval of Recombinant Human Interferon α2b in China

2 Sales of Recombinant Human Interferon α2b in China, 2013-2017
2.1 Sales Value of Recombinant Human Interferon α2b
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Recombinant Human Interferon α2b
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Recombinant Human Interferon α2b by Dosage Form in China, 2013-2017
2.3.1 Sales of Recombinant Human Interferon α2b Gels
2.3.2 Sales of Recombinant Human Interferon α2b Sprays
2.3.3 Sales of Recombinant Human Interferon α2b Suppositories
2.3.4 Sales of Recombinant Human Interferon α2b Injections
2.3.5 Sales of Recombinant Human Interferon α2b Eye Drops
2.3.6 Sales of Recombinant Human Interferon α2b Capsules
2.3.7 Sales of Recombinant Human Interferon α2b Creams (Ointments)
2.3.8 Sales of Recombinant Human Interferon α2b Tablets

3 Major Manufacturers of Recombinant Human Interferon α2b in China, 2013-2017
3.1 Analysis on Market Share of Major Manufacturers of Recombinant Human Interferon α2b
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Shanghai Huaxin High Biotechnology Inc.
3.3 Zhaoke Pharmaceutical (Hefei) Co. Ltd.
3.4 Schering-Plough
3.5 Beijing Kawin Technology Share-Holding Co., Ltd.
3.6 Tianjin Sinobioway Biomedicine Co., Ltd.

4 Prices of Recombinant Human Interferon α2b in China, 2017-2018
4.1 Shanghai Huaxin High Biotechnology Inc. (Xinhuanuo)
4.2 Zhaoke Pharmaceutical (Hefei) Co. Ltd. (Yallaferon)
4.3 Schering-Plough (Intron A)
4.4 Beijing Kawin Technology Share-Holding Co., Ltd. (Kawin Yisheng)
4.5 Tianjin Sinobioway Biomedicine Co., Ltd. (Alfaron)

5 Prospect of China's Recombinant Human Interferon α2b Market, 2018-2022
5.1 Major Factors Influencing Development of Recombinant Human Interferon α2b in China
5.2 Forecast on Market Size of Recombinant Human Interferon α2b in China
5.3 Forecast on Market Trend of Recombinant Human Interferon α2b in China

List of Charts

Chart Governmental Approval of Recombinant Human Interferon α2b in China
Chart Sales of Recombinant Human Interferon α2b in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b in Parts of China, 2013-2017
Chart Sales Volume of Recombinant Human Interferon α2b in China, 2013-2017
Chart Sales Volume of Recombinant Human Interferon α2b in Parts of China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Gels in China, 2013-2017
Chart Sales Volume of Recombinant Human Interferon α2b Gels in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Sprays in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Suppositories in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Injections in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Eye Drops in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Capsules in China, 2013-2017
Chart Sales Value of Recombinant Human Interferon α2b Tablets in China, 2013-2017
Chart Market Share by Sales Value of Top 5 Manufacturers of Recombinant Human Interferon α2b in China, 2013-2017
Chart Sales Value of Shanghai Huaxin High Biotechnology Inc.'s Recombinant Human Interferon α2b, 2013-2017
Chart Sales Volume of Shanghai Huaxin High Biotechnology Inc.'s Recombinant Human Interferon α2b, 2013-2017
Chart Sales Value of Zhaoke Pharmaceutical (Hefei) Co. Ltd.'s Recombinant Human Interferon α2b, 2013-2017
Chart Sales Value of Schering-Plough's Recombinant Human Interferon α2b, 2013-2017
Chart Sales Volume of Schering-Plough's Recombinant Human Interferon α2b, 2013-2017
Chart Sales Value of Beijing Kawin Technology Share-Holding Co., Ltd.'s Recombinant Human Interferon α2b, 2013-2017
Chart Prices of Shanghai Huaxin High Biotechnology Inc.'s Recombinant Human Interferon α2b (Xinhuanuo) in Parts of China, 2017-2018
Chart Prices of Zhaoke Pharmaceutical (Hefei) Co. Ltd.'s Recombinant Human Interferon α2b (Yallaferon) in Parts of China, 2017-2018
Chart Prices of Schering Plough's Recombinant Human Interferon α2b (Intron A) in Parts of China, 2017-2018
Chart Forecast on Sales Value of Recombinant Human Interferon α2b in China, 2018-2022

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs